| scholarly article | Q13442814 |
| P50 | author | Ulrich Kalinke | Q47156951 |
| Thomas Ebensen | Q90123871 | ||
| Kai Schulze | Q100747400 | ||
| P2093 | author name string | Carlos A Guzmán | |
| Stephanie Trittel | |||
| Darío Lirussi | |||
| Ines Liebich | |||
| Veronica Duran | |||
| P2860 | cites work | Functional role of type I and type II interferons in antiviral defense | Q24276429 |
| Cyclic di-GMP sensing via the innate immune signaling protein STING | Q24338485 | ||
| Induction and function of type I and III interferon in response to viral infection | Q27010065 | ||
| Cyclic [G(2′,5′)pA(3′,5′)p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase | Q27678007 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response | Q28510485 | ||
| TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation | Q28513332 | ||
| T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
| Interferon induction and function at the mucosal surface | Q30661545 | ||
| Antigen trafficking and accessory cell function in respiratory epithelial cells | Q30759145 | ||
| "Upstream Analysis": An Integrated Promoter-Pathway Analysis Approach to Causal Interpretation of Microarray Data | Q31126994 | ||
| A framework for oligonucleotide microarray preprocessing. | Q34149103 | ||
| The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides | Q34151349 | ||
| The cyclic dinucleotide c-di-AMP is an allosteric regulator of metabolic enzyme function | Q34199004 | ||
| A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. | Q34313503 | ||
| A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. | Q35328612 | ||
| Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity | Q35634752 | ||
| Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. | Q35836140 | ||
| STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade | Q35858368 | ||
| The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets | Q36139555 | ||
| Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A. | Q36204578 | ||
| STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice | Q36288074 | ||
| STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity | Q36394326 | ||
| Type I interferon as a stimulus for cross-priming | Q37027815 | ||
| The cell biology of cross-presentation and the role of dendritic cell subsets | Q37082455 | ||
| Cyclic-di-GMP and cyclic-di-AMP activate the NLRP3 inflammasome | Q37252429 | ||
| New developments in the induction and antiviral effectors of type I interferon | Q37292441 | ||
| Adjuvant activity of type I interferons | Q37309272 | ||
| Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. | Q37424192 | ||
| STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. | Q37502349 | ||
| Cyclic di-nucleotides: new era for small molecules as adjuvants. | Q37940637 | ||
| Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response | Q38176613 | ||
| The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells | Q38874315 | ||
| Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells | Q39014554 | ||
| Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes | Q40864032 | ||
| Ultrasensitive quantification of TAP-dependent antigen compartmentalization in scarce primary immune cell subsets | Q41500470 | ||
| Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling | Q41851410 | ||
| Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. | Q42211517 | ||
| Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. | Q42213627 | ||
| Early inflammatory response to the saponin adjuvant Matrix-M in the pig. | Q42273426 | ||
| Sec61 in antigen cross-presentation | Q43164223 | ||
| Interferon-beta is required for interferon-alpha production in mouse fibroblasts | Q43412872 | ||
| Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant | Q44205583 | ||
| Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 | ||
| A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells | Q45345591 | ||
| Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation | Q46674193 | ||
| β2-Adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells. | Q46738225 | ||
| Leupeptin, a calpain inhibitor, protects inner ear hair cells from aminoglycoside ototoxicity | Q50464679 | ||
| The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. | Q52015962 | ||
| MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo. | Q54487555 | ||
| Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells | Q56881042 | ||
| Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway | Q71151636 | ||
| Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody | Q73479961 | ||
| The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties | Q79450264 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 100-111 | |
| P577 | publication date | 2017-07-19 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway | |
| P478 | volume | 22 |
| Q98177707 | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
| Q58764447 | Genetic Engineering of Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype |
| Q64071164 | Priming of HIV-1-specific CD8 T cells with strong functional properties from naïve T cells |
| Q89472144 | Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development |
| Q64229218 | The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization |
| Q91999288 | The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells |
| Q64076929 | The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells |
Search more.